News | Magnetic Resonance Imaging (MRI) | September 14, 2018

Philips Launches Ingenia Ambition X 1.5T MR

Ingenia Ambition X combines fully sealed BlueSeal magnet technology and workflow innovations for a step-change in productivity

Philips Launches Ingenia Ambition X 1.5T MR

September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T magnetic resonance imaging (MRI) scanner. It is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter and simpler path to enabling a confident diagnosis. The first commercial installation of the Ingenia Ambition X was recently completed at Spital Uster Hospital, a major provider of extended primary healthcare in the canton of Zurich, Switzerland. The Ingenia Ambition X is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

In radiology, meeting the need for high productivity and an improved patient experience while ensuring excellence in imaging can be daunting. The perception is often that MR represents a trade-off between productivity and image quality. The Ingenia Ambition X provides what Philips calls leading-edge MRI capabilities while helping to increase overall productivity, combining its BlueSeal magnet with innovations that can help reduce downtime, enable single-operator workflow and speed up exam times by up to 50 percent.

Incorporating Philips' BlueSeal fully-sealed magnet, the Ingenia Ambition X is the world's first MR system to enable helium-free operations [3], reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The fully-sealed system does not require a vent pipe and is around 900 kg lighter than its predecessor, significantly reducing the siting challenges presented by conventional magnets and lowering construction costs.

"We are very proud to be the first hospital in the world to offer this new cutting-edge, resource-friendly MRI technology to our patients," said Andreas Steinauer, M.D., chief radiologist at Spital Uster Hospital, Switzerland. "With the new Philips Ingenia Ambition X our patients can have the best of two worlds: leading MRI technology with a smaller footprint. This new leaner platform will allow more sites to deliver advanced MRI technology to their patients, helping to improve patient care."

The Ingenia Ambition X includes a range of new features that combine to deliver a step-change in productivity, according to Philips. With Philips' EasySwitch solution, the BlueSeal's magnetic field can be easily turned off if an item becomes stuck in the bore. Once the problem is resolved, an in-house or Philips technician can initiate an automated ramp-up to bring the magnet back to field, minimizing operational downtime. A conventional MR can require two staff to manage daily operations. The Ingenia Ambition X combines guided patient setup and Adaptive Intelligence-driven SmartExam analytics for automatic planning, scanning and processing. This frees up time to enable a single operator to manage the full scan from the patient's side with just a single touch of a button.

Philips Compressed SENSE is an advanced acceleration application that reduces exam times by up to 50 percent. In addition, Philips VitalEye is a unique approach to detecting patient physiology and breathing movement. VitalEye technology and algorithms intelligently extract signs of breathing – allowing routine exam set-up time to occur in less than a minute, even for less experienced operators. Together, these innovations help to standardize and speed up workflow, allowing clinicians to focus on the patient.

Read the article "Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI"

For more information: www.usa.philips.com/healthcare

Related Content

Novel Coronavirus 2019-nCoV Pneumonia

Image by _freakwave_ from Pixabay 

News | Computed Tomography (CT) | February 16, 2020
February 16, 2020 — The following statement was issued by the U.S.
negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020
As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus
SIR-Spheres Y-90 resin

SIR-Spheres Y-90 resin microspheres are released into the hepatic artery.

News | Nuclear Imaging | February 14, 2020
February 14, 2020 —  ...
MolecuLight’s i:X procedure in wound care
News | Radiology Imaging | February 13, 2020
February 13, 2020 — MolecuLight Inc., a leader in handheld fluorescence imaging for real-time detection of bacteria i
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke

Appearance of same unenhanced CT scan on three reading systems: E-2620 monitor (Barco) (A), Galaxy S8 Plus (Samsung) smartphone (B) and ThinkPad T460s laptop computer (Lenovo) (C).

News | Computed Tomography (CT) | February 12, 2020
February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV throm
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
CT image of Novel Coronavirus 2019-nCoV from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

An image from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

Feature | Computed Tomography (CT) | February 11, 2020
February 11, 2020 — The Radiological Society of North America (RSNA) jo
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth

Image courtesy of GlobalData

News | Computed Tomography (CT) | February 10, 2020
February 10, 2020 — The compute...